## Abstract To determine the longβterm efficacy of botulinum toxin (BTX) treatments, we analyzed longitudinal followβup data on 45 patients (32 women; mean age, 68.8 years) currently followed in the Baylor College of Medicine Movement Disorders Clinic, who have received BTX treatments continuously
β¦ LIBER β¦
Safety and efficacy of botulinum toxin type A following long-term use
β Scribed by M. Naumann; A. Albanese; F. Heinen; G. Molenaers; M. Relja
- Book ID
- 111064962
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 595 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1351-5101
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Long-term botulinum toxin efficacy, safe
β
Nicte I. Mejia; Kevin Dat Vuong; Joseph Jankovic
π
Article
π
2005
π
John Wiley and Sons
π
English
β 120 KB
Long-term safety of botulinum toxin type
β
Markus Naumann; A. Peter Moore
π
Article
π
2003
π
John Wiley and Sons
π
English
β 36 KB
Long-term efficacy and safety of botulin
β
Daniel Truong; Matthew Brodsky; Mark Lew; Allison Brashear; Joseph Jankovic; Eri
π
Article
π
2010
π
Elsevier Science
π
English
β 228 KB
The long-term efficacy and safety of bot
β
A. Kemal Erdemoglu; Ayhan Varlibas
π
Article
π
2007
π
Springer
π
English
β 408 KB
Long-term faecal incontinence following
β
M. Smith; F. Frizelle
π
Article
π
2004
π
John Wiley and Sons
π
English
β 41 KB
Long-term safety, efficacy, dosing, and
β
Brian Berman; Lauren Seeberger; Rajeev Kumar
π
Article
π
2004
π
John Wiley and Sons
π
English
β 64 KB
## Abstract Shortβterm studies of cervical dystonia (CD) have demonstrated botulinum toxin type B (Bot B) to be safe and efficacious at doses of 5,000 to 10,000 units, but few longβterm studies have been published and the safety and efficacy of higher doses has not been established. Additionally, t